Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$4.86 - $13.07 $45,975 - $123,642
-9,460 Closed
0 $0
Q4 2020

Jun 22, 2023

BUY
$9.48 - $12.84 $89,680 - $121,466
9,460 New
9,460 $119,000
Q3 2020

Jun 26, 2023

BUY
$8.67 - $10.82 $82,018 - $102,357
9,460 New
9,460 $92,000
Q2 2020

Jun 26, 2023

BUY
$7.8 - $11.52 $73,788 - $108,979
9,460 New
9,460 $94,000
Q1 2020

Jul 12, 2023

BUY
$5.98 - $13.09 $56,570 - $123,831
9,460 New
9,460 $83,000
Q1 2020

Mar 30, 2023

BUY
$5.98 - $13.09 $11,403 - $24,962
1,907 Added 25.25%
9,460 $83,000
Q1 2020

May 15, 2020

BUY
$5.98 - $13.09 $56,570 - $123,831
9,460 New
9,460 $84,000
Q4 2019

Feb 14, 2020

SELL
$5.71 - $9.22 $43,127 - $69,638
-7,553 Closed
0 $0
Q3 2019

Jul 12, 2023

BUY
$5.88 - $12.35 $44,411 - $93,279
7,553 New
7,553 $44,000
Q2 2019

Jul 12, 2023

BUY
$9.44 - $13.12 $71,300 - $99,095
7,553 New
7,553 $90,000
Q1 2019

Jul 13, 2023

BUY
$12.07 - $17.54 $91,164 - $132,479
7,553 New
7,553 $91,000
Q1 2019

Mar 30, 2023

BUY
$12.07 - $17.54 $91,164 - $132,479
7,553 New
7,553 $91,000
Q1 2019

May 16, 2019

SELL
$12.07 - $17.54 $160,808 - $233,685
-13,323 Reduced 63.82%
7,553 $91,000
Q1 2019

May 15, 2019

BUY
$12.07 - $17.54 $160,808 - $233,685
13,323 Added 176.39%
20,876 $612,000
Q4 2018

Jul 13, 2023

BUY
$11.25 - $16.17 $84,971 - $122,132
7,553 New
7,553 $94,000
Q4 2018

Feb 14, 2019

BUY
$11.25 - $16.17 $69,581 - $100,011
6,185 Added 452.12%
7,553 $95,000
Q3 2018

Jul 13, 2023

BUY
$12.82 - $17.88 $81,381 - $113,502
6,348 New
6,348 $94.2 Million
Q3 2018

Nov 14, 2018

SELL
$12.82 - $17.88 $63,843 - $89,042
-4,980 Reduced 78.45%
1,368 $20,000
Q4 2017

Feb 15, 2018

BUY
$13.96 - $29.05 $88,618 - $184,409
6,348 New
6,348 $164,000
Q3 2017

Nov 14, 2017

SELL
$13.91 - $15.31 $180,496 - $198,662
-12,976 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
12,976
12,976 $181,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About CONCERT PHARMACEUTICALS, INC.


  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.